EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Date

Title

File

Times

2021-09-23

NEXT DAY DISCLOSURE RETURN

1165

2021-09-21

NEXT DAY DISCLOSURE RETURN

1111

2021-09-20

NEXT DAY DISCLOSURE RETURN

1167

2021-09-16

NEXT DAY DISCLOSURE RETURN

1167

2021-09-15

NEXT DAY DISCLOSURE RETURN

1183

2021-09-14

NEXT DAY DISCLOSURE RETURN

1231

2021-09-13

NEXT DAY DISCLOSURE RETURN

1163

2021-09-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2021

1198

2021-08-30

SUPPLEMENTAL ANNOUNCEMENT RELATING TO DISCLOSEABLE TRANSACTION PRODUCT INTERESTS TRANSFER AGREEMENT RELATING TO IODIZED LECITHIN CAPSULES

1264

2021-08-20

NEXT DAY DISCLOSURE RETURN

1286

2021-08-19

NEXT DAY DISCLOSURE RETURN

1183

2021-08-17

NEXT DAY DISCLOSURE RETURN

1252

2021-08-12

INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2021

1230

2021-08-12

INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021

1288

2021-08-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021

1279

2021-07-29

NOTICE OF BOARD MEETING

1416

2021-07-20

POSITIVE PROFIT ALERT

1373

2021-07-19

VOLUNTARY ANNOUNCEMENT FIRST PATIENT FIRST VISIT COMPLETED IN THE PRC IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS RELATING TO THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

1377

2021-07-06

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2021

1307

2021-06-28

NEXT DAY DISCLOSURE RETURN

1394

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT